From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialty Care>
  3. HIV/AIDS>
  4. Top Stories>
  5. Archives

Top Stories for HIV/AIDS: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

  •  
Items 1-10 of 10 are shown

Top HIV/AIDS Stories of 2007

A perspective on the year’s most important stories in HIV medicine

Top HIV/AIDS Stories of 2006

The ACC editors offer their perspective on the year’s most important stories in HIV medicine.

New CDC HIV Testing Guidelines for Adults and Adolescents

Routine HIV screening should now be offered at all points of care to all individuals aged 13 to 64, regardless of their potential risk for infection.

One Pill, Once Daily = Triple Therapy for HIV

A single tablet contains efavirenz, tenofovir, and FTC, one of the most effective triple-drug regimens available for treatment-naive patients.

Resistance Testing: A New Emphasis on Detecting Transmitted Resistance

All HIV-infected patients should undergo genotype testing prior to initiation of antiretroviral therapy.

Standard Triple-Drug Regimens Remain the Best for Initial Therapy

Efavirenz-based regimens appear to be particularly effective.

Expanded HIV Treatment in Resource-Poor Countries

Initial concerns that antiretroviral therapy would be less effective in resource-poor settings - or that patients there would be less adherent - appear to be unfounded.

Promising New Options for Treatment-Experienced Patients

Even triple-class–experienced patients can achieve virologic suppression with some of the new agents now available.

Discouraging News on Structured Treatment Interruption

Structured treatment interruptions that allow CD4 counts to drop below 350 cells/mm3 are unsafe and should not be recommended.

XDR TB: A Growing Public Health Concern

Global increases in multidrug-resistant and extensively drug-resistant TB are threatening both TB and HIV treatment programs worldwide and raise concerns about a future epidemic of virtually untreatable TB.

  •  
Items 1-10 of 10 are shown
Copyright © 2008. Massachusetts Medical Society. All rights reserved.